Form D · Other Health Care

INCOG BioPharma Services, Inc.

Fishers, IN · CIK 0001825530

Offering snapshot reported May 29, 2024 · SEC filing

Reported sold: $42.9M
Investors reported: 1
Minimum accepted: $0
First sale: May 14, 2024

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 29, 2024	Initial	$42,864,002	No comparison	1	SEC filing
May 29, 2024	Amendment	$42,864,002	$0vs May 29, 2024	1	SEC filing
May 10, 2022	Initial	$14,999,250	No comparison	5	SEC filing
Sep 29, 2020	Initial	$28,767,000	No comparison	3	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-514524

Source: Form D, filed May 29, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Madhu Balachandran	Director
Karen Blair	Director
Fabrizio Bonanni	Director
Doug Dayoff	Executive
Tedd Green	Executive
Cory Lewis	Director, Executive
Keith Skerrett	Director
Martin Van Trieste	Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:

12050 Exit 5 Parkway
Fishers, IN, 46037